MARKET

COLL

COLL

Collegium Pharmaceutical Inc
NASDAQ
47.91
+0.48
+1.01%
After Hours: 48.43 +0.52 +1.09% 18:53 12/05 EST
OPEN
47.59
PREV CLOSE
47.43
HIGH
47.92
LOW
46.81
VOLUME
274.81K
TURNOVER
--
52 WEEK HIGH
48.37
52 WEEK LOW
23.23
MARKET CAP
1.51B
P/E (TTM)
29.88
1D
5D
1M
3M
1Y
5Y
1D
1 Mooning Stock with Promising Prospects and 2 Facing Challenges
Barchart · 15h ago
Collegium Pharmaceutical, Inc. (COLL) Hits Fresh High: Is There Still Room to Run?
NASDAQ · 1d ago
Ensign Group Expands Foothold in Three U.S. States With Facility Buyouts
NASDAQ · 2d ago
Weekly Report: what happened at COLL last week (1124-1128)?
Weekly Report · 4d ago
Collegium Pharmaceutical (COLL): Exploring Valuation After Recent Share Price Surge
Simply Wall St · 11/27 16:33
Weekly Report: what happened at COLL last week (1117-1121)?
Weekly Report · 11/24 09:54
Has Analyst Spotlight on COLL Revealed a Turning Point in Its Competitive Advantage?
Simply Wall St · 11/21 20:16
Why 2025 is a Dynamic and Transformative Year for Collegium
NASDAQ · 11/21 13:04
More
About COLL
Collegium Pharmaceutical, Inc. is a diversified biopharmaceutical company. The Company has developed, licensed, and acquired a portfolio of products for use in the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. Its commercial products include Jornay PM (Jornay), Belbuca, Xtampza ER (Xtampza), Nucynta ER and Nucynta IR (Nucynta Products), and Symproic in the United States. Its Jornay is a central nervous system (CNS) stimulant prescription medicine for the treatment of ADHD. The Belbuca is a buccal film that contains buprenorphine for severe and persistent pain. Xtampza ER is an abuse-deterrent, extended-release, oral formulation of oxycodone. The Xtampza ER is a pain treatment option designed with abuse deterrent properties. The Nucynta Products are ER and IR oral formulations of tapentadol. Nucynta ER is indicated for the management of severe and persistent pain that requires an extended treatment period with a daily opioid analgesic.

Webull offers Collegium Pharmaceutical Inc stock information, including NASDAQ: COLL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, COLL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading COLL stock methods without spending real money on the virtual paper trading platform.